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Figure S1. SNOM-IR-FEL images of normal cells: (a) topography; transmission images: (b) Amide I; (c) 
Amide II; (d) Lipids; and, (e) DNA. The colour scale bar arrow in (b) applies to (b-e) and indicates increasing 










Figure S2. SNOM-IR-FEL images of low-grade dyskaryosis: (a) topography; transmission images: (b) Amide 
I; (c) Amide II; (d) Lipids; and, (e) DNA. The colour scale bar arrow in (b) applies to (b-e) and indicates increasing 





Figure S3. SNOM-IR-FEL images of high-grade dyskaryosis: (a) topography; transmission images: (b) 
Amide I; (c) Amide II; (d) Lipids; and, (e) DNA. The colour scale bar arrow in (b) applies to (b-e) and 
indicates increasing biomarker absorption. SNOM-IR-FEL: Scanning near-field optical microscopy coupled 
















The SNOM-IR-FEL images and associated topography of the pre-invasive lesion (CIN2, HGCGIN) are  






Figure S4. SNOM-IR-FEL images of adenocarcinoma Stage 1B1: (a) topography; transmission images: 
(b) Amide I (imaged from different site to topography shown here); (c) Amide II; and, (d) Lipids. (e) 
Topography of cells from a second area; and, (f) the corresponding SNOM transmission image for the DNA 
biomarker. The colour scale bar arrow in (b) applies to (b-d, f) and indicates increasing biomarker absorption. 





Figure S5. Transmission SNOM-IR-FEL: Hotelling T2 versus Q Residuals graphs for the type of cells 
according to each biomarker response: (a) Amide I; (b) Amide II; (c) Lipids; and, (d) DNA. All 5 samples 
fell within the 95% confidence limits (blue dotted line), and shows there were no outliers. The score for 
Hotelling T2 ranged from 96.51% to 97.56%; whilst the score for Q residuals ranged from 2.44% and 3.49%. 
CIN2, HGCGIN: Cervical intraepithelial neoplasia 2, high-grade cervical glandular intraepithelial neoplasia; 




Figure S6. Transmission SNOM-IR-FEL: Validation of the PCA model using Q Residuals to measure 
variation outside the PCA model for each sample according each biomarker response: (a) Amide I; (b) Amide 
II; (c) Lipids; and, (d) DNA. The optimal score for Q Residuals is 0% and here ranged from 2.44% to 3.49%. 
All 5 samples fell within the 95% confidence limits (blue dotted line), shows there were no outliers and that the 
data fits the model well. CIN2, HGCGIN: Cervical intraepithelial neoplasia 2, high-grade cervical glandular 





Figure S7. Transmission SNOM-IR-FEL: Validation of the PCA model using Hotelling T2 to measure 
variation within the PCA model for each sample according each biomarker response: (a) Amide I; 
(b) Amide II; (c) Lipids; and, (d) DNA. The optimal score for Hotelling T2 is 100% and here ranged from 
96.51% to 97.56%. All 5 samples fell within the 95% confidence limits (blue dotted line), shows there were no 
outliers and that the data fits the model well. CIN2, HGCGIN: Cervical intraepithelial neoplasia 2, high-grade 
cervical glandular intraepithelial neoplasia; SNOM-IR-FEL: Scanning near-field optical microscopy coupled 







Figure S8: ATR-FTIR spectroscopy: Average infrared spectra of cell types. 
 
ATR-FTIR spectroscopy: Attenuated total reflection Fourier-transform infrared spectroscopy; CIN2, 






Figure S9. ATR-FTIR spectroscopy: Scores plot of 1st and 2nd principal components at a 95% confidence level. 
ATR-FTIR spectroscopy: Attenuated total reflection Fourier-transform infrared spectroscopy; CIN2, HGCGIN: 




Figure S10. AFM imaging of adenocarcinoma Stage 1B1: (a) Optical image (×10 magnification) identifying cells 
for investigation by AFM; and, (b) AFM topography image of two intermediate glandular cells [area 2 in (a)], the 
lower cell has two nuclei. The cells exhibit a long axis of ~75 µm. The cell thickness was measured at ~200 nm, 
whereas the nuclei protruded  ~1 µm in height from the substrate. (c) AFM topography; and, (d) deflection image of 
a cell identified [area 1 in (a)] as having a single enlarged nucleus separated from the rest of the cell by a halo. 






Figure S11. The computational steps taken in processing the data. 
